130 related articles for article (PubMed ID: 28479744)
1. High Throughput Virtual Screening to Identify Novel natural product Inhibitors for MethionyltRNA-Synthetase of Brucella melitensis.
Kumari M; Chandra S; Tiwari N; Subbarao N
Bioinformation; 2017; 13(1):8-16. PubMed ID: 28479744
[TBL] [Abstract][Full Text] [Related]
2. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
Ojo KK; Ranade RM; Zhang Z; Dranow DM; Myers JB; Choi R; Nakazawa Hewitt S; Edwards TE; Davies DR; Lorimer D; Boyle SM; Barrett LK; Buckner FS; Fan E; Van Voorhis WC
PLoS One; 2016; 11(8):e0160350. PubMed ID: 27500735
[TBL] [Abstract][Full Text] [Related]
3. Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach.
Rowaiye AB; Ogugua AJ; Ibeanu G; Bur D; Asala MT; Ogbeide OB; Abraham EO; Usman HB
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0009799. PubMed ID: 35312681
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
5. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
Gupta M; Prasad Y; Sharma SK; Jain CK
J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening.
Finn J; Stidham M; Hilgers M; G C K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3932-7. PubMed ID: 18590962
[TBL] [Abstract][Full Text] [Related]
7. Proteome-Wide Screening of Potential Vaccine Targets against
Malik M; Khan S; Ullah A; Hassan M; Haq MU; Ahmad S; Al-Harbi AI; Sanami S; Abideen SA; Irfan M; Khurram M
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851141
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
9. Exploring
Elbaramawi SS; Eissa AG; Noureldin NA; Simons C
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765071
[TBL] [Abstract][Full Text] [Related]
10. Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.
Liu C; He G; Jiang Q; Han B; Peng C
Int J Mol Sci; 2013 Jul; 14(7):14225-39. PubMed ID: 23839093
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of Food and Drug Admnistration (FDA) approved library to identify a potential inhibitor of
Vemula D; Mohanty S; Bhandari V
Heliyon; 2024 Mar; 10(6):e27602. PubMed ID: 38509977
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening.
Kumari M; Subbarao N
J Biomol Struct Dyn; 2022 Nov; 40(18):8185-8196. PubMed ID: 33826470
[TBL] [Abstract][Full Text] [Related]
13. Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study.
Alabbas AB
Saudi Pharm J; 2023 Sep; 31(9):101745. PubMed ID: 37638221
[TBL] [Abstract][Full Text] [Related]
14. Correction: Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
Ojo KK; Ranade RM; Zhang Z; Dranow DM; Myers JB; Choi R; Nakazawa Hewitt S; Edwards TE; Davies DR; Lorimer D; Boyle SM; Barrett LK; Buckner FS; Fan E; Van Voorhis WC
PLoS One; 2016; 11(9):e0163641. PubMed ID: 27658298
[TBL] [Abstract][Full Text] [Related]
15. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
[TBL] [Abstract][Full Text] [Related]
16. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
17. Identification of Small-Molecule Inhibitors of
Bie P; Yang X; Zhang C; Wu Q
Front Microbiol; 2019; 10():2936. PubMed ID: 32038511
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
Mathew SM; Benslimane F; Althani AA; Yassine HM
Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
[No Abstract] [Full Text] [Related]
20. Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach.
Hazra S; Ray AS; Rahaman CH
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
